Blood cell study in inflammatory bowel disease flare-ups
Part of Digestive system clinical trials.
This study looks at how certain blood cells change during a severe flare-up of inflammatory bowel disease (IBD), like Crohn's disease or ulcerative colitis. The goal is to better understand inflammation and potentially improve future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a severe flare-up of inflammatory bowel disease that requires hospital care or an endoscopy.
- You are willing to participate and do not object to the study.
- You are not pregnant or breastfeeding.
- You do not have HIV, hepatitis B, or hepatitis C.
- You do not have untreated latent tuberculosis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is gathering information from people with active Crohn's disease or ulcerative colitis, and from people without IBD. Researchers will look at samples from the colon to learn more about these conditions.
This study looks at how your blood tests (inflammation levels) change after you start or adjust your treatment for ulcerative colitis or Crohn's disease. It also checks how your gut heals by looking at tissue samples from a follow-up colonoscopy.
This study looks at whether certain blood tests (called inflammatory biomarkers) can help measure how active your inflammatory bowel disease (Crohn's disease or ulcerative colitis) is. It may help doctors better track your condition and guide treatment, without needing invasive procedures.
This study looks at blood cells from children with and without inflammatory bowel disease or rectal bleeding. It aims to understand how these cells behave, which may lead to new treatments.
This study collects blood and tissue samples to better understand how the immune system behaves in people with inflammatory bowel disease (IBD), which includes Crohn's disease and ulcerative colitis. It aims to advance research rather than test a specific new treatment, and it also enrolls healthy volunteers for comparison.
This study is looking at how the immune system works in people with inflammatory bowel disease (IBD), which includes conditions like Crohn's disease and ulcerative colitis. By comparing blood or tissue samples from people with and without IBD, researchers hope to find better ways to treat the disease in the future.
Hear when a new Inflammatory Bowel Disease (IBD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.